Inactive Instrument

Bayer Aktiengesellschaft Share Price Other OTC

Equities

BAYRY

US0727303028

Pharmaceuticals

Financials

Sales 2024 * 47.09B 50.47B 4,031B Sales 2025 * 47.95B 51.39B 4,104B Capitalization 26.87B 28.8B 2,300B
Net income 2024 * 2.08B 2.23B 178B Net income 2025 * 3.17B 3.39B 271B EV / Sales 2024 * 1.27 x
Net Debt 2024 * 33.1B 35.48B 2,834B Net Debt 2025 * 29.67B 31.8B 2,540B EV / Sales 2025 * 1.18 x
P/E ratio 2024 *
12.5 x
P/E ratio 2025 *
8.41 x
Employees -
Yield 2024 *
0.4%
Yield 2025 *
0.85%
Free-Float 99.97%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Bayer Aktiengesellschaft

Managers TitleAgeSince
Chief Executive Officer 57 31/03/23
Director of Finance/CFO 55 25/04/18
Chief Tech/Sci/R&D Officer 55 31/03/20
Members of the board TitleAgeSince
Director/Board Member 68 31/03/17
Director/Board Member 68 31/03/17
Director/Board Member 67 31/03/21
More insiders
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.5%). Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).
Calendar
More about the company